Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.42 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.42 |
| ▸ | TACR3 | P29371 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29004148 | 1.00 | OPRM1 (0.42) | OPRM1ABCB11THRBNR1I2CHRM2 | |
| Hydrochloric Acid SCHEMBL28365291 | 0.99 | OPRM1 (0.41) | OPRM1ABCB11THRBNR1I2CHRM2 | |
| Hydrochloric Acid SCHEMBL1160455 | 0.99 | OPRM1 (0.41) | OPRM1ABCB11THRBNR1I2CHRM2 | |
| SCHEMBL5673263 | 0.87 | OPRM1 (0.44) | OPRM1THRBCYP2C19HPGDALDH1A1 | |
| SCHEMBL6140943 | 0.87 | OPRM1 (0.44) | OPRM1THRBCYP2C19HPGDALDH1A1 | |
| SCHEMBL7055714 | 0.87 | OPRM1 (0.44) | OPRM1THRBCYP2C19HPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL4846461 | 0.86 | OPRM1 (0.43) | OPRM1THRBCYP2C19HPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL5444914 | 0.86 | OPRM1 (0.43) | OPRM1THRBCYP2C19HPGDALDH1A1 | |
| SCHEMBL6630179 | 0.86 | ALOX5 (0.42) | OPRM1CYP2C19HPGDALDH1A1MAPT | |
| SCHEMBL6632878 | 0.80 | ADRB2 (0.45) | OPRM1ABCB11THRBNR1I2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5204469-A | PROCESS FOR THE PREPARATION OF AN N-PHENYLACETIC DERIVATIVE OF TETRAHYDROTHIENO(3,2-C)PYRIDINE AND ITS CHEMICAL INTERMEDIATE | SANOFI (FR) | 1993-04-20 | — | — | US | claimed |
| US-8063217-B2 | Process for preparation of methyl-(+)-(S)-alpha-(2-chlorophenyl)-6, 7-dihydrothieno[3,2-C]pyridine-5(4H) -acetic acid methyl ester or salts thereof having higher chiral purity and products thereof | RPG LIFE SCIENCES LIMITED (IN) | 2011-11-22 | — | — | US | disclosed |
| EP-2298777-A2 | METHOD FOR PREPARING CLOPIDOGREL AND ITS DERIVATIVES | Enzytech, Ltd. (KR) | 2011-03-23 | — | — | EP | disclosed |
| US-20100004453-A1 | PROCESS FOR PREPARATION OF METHYL-(+)-(S)-ALPHA-(2-CHLOROPHENYL)-6, 7-DIHYDROTHIENO[3,2-C]PYRIDINE-5 (4H) -ACETIC ACID METHYL ESTER OR SALTS THEREOF HAVING HIGHER CHIRAL PURITY AND PRODUCTS THEREOF | RPG LIFE SCIENCES LIMITED An Indian Company of Ceat Mahal (IN) | 2010-01-07 | — | — | US | disclosed |
| EP-1902058-A2 | A PROCESS FOR PREPARATION OF METHYL-(+)-(S)-ALPHA-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER OR SALTS THEREOF HAVING HIGHER CHIRAL PURITY AND PRODUCTS THEREOF | RPG Life Sciences Limited (IN) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007032023-A2 | A PROCESS FOR PREPARATION OF METHYL-(+)-(S)-ALPHA-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER OR SALTS THEREOF HAVING HIGHER CHIRAL PURITY AND PRODUCTS THEREOF | RPG LIFE SCIENCES LIMITED (IN) | 2007-03-22 | — | — | WO | disclosed |
| EP-1404681-A1 | PROCESS FOR THE PREPARATION OF TETRAHYDROTHIENO [3,2-C] PYRIDINE DERIVATIVES | Brantford Chemicals Inc. (CA) | 2004-04-07 | — | — | EP | disclosed |
| EP-0981525-B1 | (2-(2-THIENYL)-ETHYLAMINO)-(2-HALOPHENYL)-ACETONITRILES AS INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF | SANOFI SYNTHELABO (FR) | 2004-01-28 | — | — | EP | disclosed |
| EP-0981524-B1 | NEW INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF | SANOFI SYNTHELABO (FR) | 2003-04-23 | — | — | EP | disclosed |
| WO-2003004502-A1 | PROCESS FOR THE PREPARATION OF TETRAHYDROTHIENO [3,2-C] PYRIDINE DERIVATIVES | BRANTFORD CHEMICALS INC. (CA) | 2003-01-16 | — | — | WO | disclosed |
| US-6215005-B1 | (2-(2-THIENYL)ETHYLAMINO)(2-HALOPHENYL)ACETONITRILE; REACTING ALKALI METAL CYANIDE, O-HALOBENZALDEHYDE AND 2-(2-THIENYL)-ETHYLAMINE; CYANATION, REDUCTION, ALKYLATION, AMINATION | SANOFI-SYNTHELABO (FR) | 2001-04-10 | — | — | US | disclosed |
| US-6180793-B1 | MULTISTAGE REACTIONS OF CLEAVAGE OF AMINE AND HYDROLYSIS | SANOFI-SYNTHELABO (FR) | 2001-01-30 | — | — | US | disclosed |
| US-6080875-A | REACTING A THIENYLGLYCIDIC DERIVATIVE WITH A PHENYLGLYCINE ESTER IN THE PRESENCE OF AN ALKALI METAL BOROHYDRIDE, DECYCLIZATION; PREPARING DRUGS FOR TREATING ANTI-PLATELET AGGREGATION AND ANTITHROMBOTIC ACTIVITIES | SANOFI-SYNTHELABO (FR) | 2000-06-27 | — | — | US | disclosed |
| EP-0981525-A1 | (2-(2-THIENYL)-ETHYLAMINO)-(2-HALOPHENYL)-ACETONITRILES AS INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF | SANOFI-SYNTHELABO (FR) | 2000-03-01 | — | — | EP | disclosed |
| EP-0981529-A1 | A NEW PROCESS FOR THE PREPARATION OF A PHARMACOLOGICALLY ACTIVE SUBSTANCE | SANOFI-SYNTHELABO (FR) | 2000-03-01 | — | — | EP | disclosed |
| EP-0981524-A1 | NEW INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF | SANOFI-SYNTHELABO (FR) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998051682-A1 | NEW INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF | SANOFI-SYNTHELABO (FR) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998051689-A1 | A NEW PROCESS FOR THE PREPARATION OF A PHARMACOLOGICALLY ACTIVE SUBSTANCE | SANOFI-SYNTHELABO (FR) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998051681-A1 | NEW INTERMEDIATES AND PROCESS FOR THE PREPARATION THEREOF | SANOFI-SYNTHELABO (FR) | 1998-11-19 | — | — | WO | disclosed |
| US-5204469-A | PROCESS FOR THE PREPARATION OF AN N-PHENYLACETIC DERIVATIVE OF TETRAHYDROTHIENO(3,2-C)PYRIDINE AND ITS CHEMICAL INTERMEDIATE | SANOFI (FR) | 1993-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004453-A1 | PROCESS FOR PREPARATION OF METHYL-(+)-(S)-ALPHA-(2-CHLOROPHENYL)-6, 7-DIHYDROTHIENO[3,2-C]PYRIDINE-5 (4H) -ACETIC ACID METHYL ESTER OR SALTS THEREOF HAVING HIGHER CHIRAL PURITY AND PRODUCTS THEREOF | ADRB3, HSD3B1, CYP2S1 | OPRM1 402/4885ABCB11 790/4885THRB 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.